Unlearn.AI is a research services and technology company headquartered in San Francisco, California. The company transforms clinical development by applying AI-powered solutions to make clinical trials smarter and help biopharma companies reach milestones faster.
Subscribe to see Unlearn.ai, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Unlearn.ai, Inc. is a healthcare company headquartered in United States. Its most recent funding round, Series C, raised $50M in January 2024. Xcout tracks 9 named people at Unlearn.ai, Inc., including Steve Herne (Chief Executive Officer). Xcout recorded 11 job postings from Unlearn.ai, Inc. in the last 90 days.
3 more named people on record for Unlearn.ai, Inc., with roles, board committees and tenure — see the full roster →
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $50M | — | |
| — | $15M | — | |
| Series B | $50M | 1 named | |
| Series B | Undisclosed | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 11 job postings from Unlearn.ai, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Unlearn.ai, Inc.'s hiring signals →
A few of Unlearn.ai, Inc.'s closest competitors — see the full list of competitors and alternatives →
Aira Health is a biotechnology research company based in Boston, Massachusetts, that provides a unified AI platform for clinical trial design and protocol development.
InSilicoTrials is a healthcare technology company headquartered in Trieste, Italy, specializing in computational modeling and AI. The platform helps pharmaceutical and device developers run clinical trial simulations to accelerate research and strengthen study design.
Formation Bio is a U.S.-based technology and drug-development company, formerly known as TrialSpark, that uses AI and software to help pharmaceutical companies develop medicines more efficiently. It serves biopharmaceutical partners by supporting clinical-trial operations and other parts of the drug-development process.
PhaseV uses causal machine learning and generative AI to optimize clinical trial designs and improve drug development processes.
HopeAI is an AI-native workspace and clinical trial design company with offices in New York and Princeton, New Jersey. The company unifies clinical evidence, specialized AI agents, and development workflows for drug development teams.
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Unlearn.ai, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.